EVENTS
2025/09/05
患者がん移植ゼブラフィッシュモデル(PDXZ)の新しい展開
2025/06/16
患者がん移植ゼブラフィッシュモデル(PDXZ)のFDA受け入れ
2025/04/15
Novel Fluorescent Dye ZMB741 for Podocytopathy Drug Screening
》discovery of stanniocalcin1 as cardiotoxic defence gene
2024/04/25
We have discovered stanniocalcin1 as cardiotoxic defence gene in 2015. the potential clinical applications of stanniocalcin in oncocardiology include its use as a biomarker for cancer therapy-induced cardiotoxicity, its potential as a therapeutic target for cardioprotection, and its role in regulating calcium homeostasis, which may be relevant for managing calcium-related cardiovascular complications in cancer patients.